SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending following the announcement that the Depository Trust & Clearing Corporation (DTCC) plans to integrate its asset tokenization platform with the Stellar blockchain. The community is actively discussing this as a major institutional validation of Stellar's utility, sparking excitement about real-world asset integration and fueling speculation of a potential short squeeze.

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is experiencing a massive rally driven by a combination of extreme short interest, high retail engagement, and speculative excitement surrounding future space milestones. The community is actively debating whether this is a legitimate short squeeze or a speculative bubble, with many traders drawing parallels to past meme stock frenzies while monitoring for potential volatility.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is experiencing a surge in investor confidence as sentiment shifts from viewing generative AI as an industry threat to a long-term growth catalyst for enterprise software. The community is actively discussing the stock's strong revenue momentum and its role as a critical AI orchestration layer, with many participants highlighting institutional buying and aggressive share repurchases as key factors driving the current rally.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is seeing increased engagement as investors debate the potential of enterprise-grade tokenization and the network's role in future financial infrastructure. Community members are actively split between those accumulating based on long-term institutional adoption and those frustrated by recent price consolidation and token dilution concerns.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group Inc. is trending as the company secures an agreement with the FDA for a potential resubmission of its melanoma treatment, sparking intense debate over regulatory transparency and the viability of its clinical data. While bulls are energized by the prospect of a third-attempt approval and speculative short-squeezes, bears maintain skepticism due to historical clinical trial rejections and long-term funding concerns.

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.

Oculis Holding AG

Oculis is trending following the failure of its eye drop clinical trial to meet primary endpoints, sparking significant investor debate regarding the company's future outlook and market valuation. The community is actively discussing the potential impact of this news on the firm's financial stability and questioning the viability of its remaining pipeline.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors rally around the companys pivot to AI and robotics, with the community highlighting its QNX operating system as a critical foundation for next-generation physical AI and autonomous vehicles. The stock is seeing significant momentum and bullish sentiment as long-term holders anticipate a potential breakout, driven by the belief that the companys safety-certified technology is increasingly vital to major industry partners.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently trending as a centerpiece of the AI infrastructure trade, drawing significant attention following reports of a massive multi-billion dollar private credit deal involving Apollo and Blackstone to accelerate its chip development. Investors and community members are actively debating the stock's position as a foundational AI play, with many highlighting its custom ASIC leadership and networking dominance while cautiously monitoring earnings expectations.

Astrotech Corp. engages in the mass spectrometry company that launches, manages and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. Its business units include 1st Detect, BreathTech, and AgLab. The company was founded in 1984 and is headquartered in Austin, TX.

Astrotech Corp

Astrotech Corp ($ASTC) is experiencing a massive rally driven by heavy short interest and speculative momentum surrounding the company's lunar infrastructure initiatives. The community is sharply divided, with bulls betting on a continued squeeze toward triple-digit price levels while bears warn of potential dilution, a lack of fundamental value, and an inevitable retracement.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella is attracting significant investor attention driven by a potential sale, with reports indicating the company is actively working with bankers to explore strategic options. The community is heavily debating the stock's valuation gap, with many viewing current levels as a deep discount for a company central to the future of robotics and edge AI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EXCLUSIVE: ENvue Medical Says Health System Renewal Extends Platform Adoption Through 2028

ENvue Medical secured a three-year renewal with a 12-hospital health system, extending its feeding tube platform use through 2028.read more...

EXCLUSIVE: ENvue Medical Locks In Multi-Year Access To Large US Nonprofit Hospital System Through 2028

ENvue Medical renewed a three-year purchasing agreement covering 90-plus hospitals across 17 states through 2028.read more...

What's Going On With ENvue Medical Stock On Thursday?

ENvue Medical shares slip premarket on Thursday after rally as Detroit hospital purchase lifts adoption to 39 sites.read more...

What's Behind The Jump In ENvue Medical Stock Today?

Shares of ENvue Medical, Inc. (NASDAQ: FEED) are surging on Tuesday after the company disclosed a new hospital system win that lifts its U.S. footprint to 39 hospitals.read more...

Small Caps Push Big Narratives, as Innovation Drives

It’s a relatively quiet session across broader markets, but beneath the surface, a wave of company-specific developments will keep traders engaged. $KBLB, $RAYA, $FEED, $ELAB, $YMT, $PAVS, $UGRO

Insider Buying: Nanovibronix (NASDAQ:FEED) Major Shareholder Purchases 240,000 Shares of Stock

Nanovibronix, Inc. (NASDAQ:FEED - Get Free Report) major shareholder Christian Michael Glibert purchased 240,000 shares of the firm's stock in a transaction dated Wednesday, January 14th. The stock...

Why Is FEED Stock Soaring Over 130% Today?

Equity

ENvue Medical announced a distribution agreement with enteral feeding supplies provider U-Deliver. 


This MedTech Stock Just Surged 81% on a Distribution Deal You Didn't See Coming

The home healthcare market continues to expand as patients and caregivers seek reliable medical solutions outside traditional hospital settings. Enteral feeding&#8212;delivering nutrition directly to the gastrointestinal tract&#8212;represents a critical segment of this market, with millions of Americans relying on tube feeding for daily nutrition and medication delivery. As care increasingly shifts from acute facilities to home environments, demand is growing for accessible, affordable products that maintain clinical standards.Shares of ENvue Medical, Inc. (NASDAQ: FEED) are soaring ...

ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through NanoVibronix and ENvue segments. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

Current Price	$0.902
Prev Close	$0.9255
Open	$0.9117
Dividend Yield	0.00%
50-Day Moving Average	$1.46
Beta	0.65
Avg. Volume	235,338.07
PE Ratio	-0.03

52-Week High	$17.40
52-Week Low	$0.84
Market Capitalization	$5.64M
EPS (Annual)	-$26.69
Price to Book	0.11
Revenue Per Employee	$182,357.14

FEED
ENvue Medical, Inc. Common Stock

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest FEED News

FEEDENvue Medical, Inc. Common Stock